- Cafepharma - Home | pharma sales, device sales, lab sales | Cafepharma
Cafepharma Today March 27 2026 - Novartis pens $2B deal for allergy biotech with potential Xolair successor Biopharma news today spans M A, clinical wins and regulatory milestones, as companies push forward in gene therapy, obesity and chronic disease treatments Novartis pens $2B deal for allergy biotech with potential Xolair successor
- Pharma Biotech Companies | Cafepharma Message Boards | Pharma Sales . . .
Anonymous discussion boards for pharmaceutical and biotech companies
- Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Anonymous discussion boards for pharmaceutical sales, medical device sales, lab diagnostics sales
- Medical Equipment Device Sales - Cafepharma
Anonymous discussion boards for medical equipment device companies
- Current News | Cafepharma
→ submit a press release → if you'd like to support our independent forums and news coverage, you can do so here
- Cafepharma News
Latest news and updates on pharmaceutical and medical sales, including breakthrough treatments and industry trends
- Cafepharma Job Board | Cafepharma Jobs
🪧 All jobs 📌 animal health sales jobs 📌 business opportunities jobs 📌 dental sales jobs 📌 lab sales jobs 📌 medtech sales jobs 📌 other jobs 📌
- Cafepharma - Home | pharma sales, device sales, lab sales | Cafepharma
Cafepharma Today March 26 2026 - Novo Nordisk's strategic U S expansion with new board appointment Biopharma headlines today highlight funding declines, AI’s growing role in drug development and a mix of clinical wins and setbacks across obesity, oncology and neurodegenerative disease
|